vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.0倍（$78.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 0.4%），Repay Holdings Corp自由现金流更多（$23.2M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -1.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
PBYI vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.0倍
$75.5M
营收增速更快
PBYI
高出27.3%
0.4%
自由现金流更多
RPAY
多$8.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $78.6M |
| 净利润 | — | $-140.1M |
| 毛利率 | 69.3% | 74.2% |
| 营业利润率 | 22.7% | -182.2% |
| 净利率 | — | -178.3% |
| 营收同比 | 27.7% | 0.4% |
| 净利润同比 | — | -3304.1% |
| 每股收益（稀释后） | $0.26 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRPAY
| Q4 25 | $75.5M | $78.6M | ||
| Q3 25 | $54.5M | $77.7M | ||
| Q2 25 | $52.4M | $75.6M | ||
| Q1 25 | $46.0M | $77.3M | ||
| Q4 24 | $59.1M | $78.3M | ||
| Q3 24 | $80.5M | $79.1M | ||
| Q2 24 | $47.1M | $74.9M | ||
| Q1 24 | $43.8M | $80.7M |
净利润PBYIRPAY
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $8.8M | $-6.4M | ||
| Q2 25 | $5.9M | $-102.3M | ||
| Q1 25 | $3.0M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $20.3M | $3.2M | ||
| Q2 24 | $-4.5M | $-4.1M | ||
| Q1 24 | $-4.8M | $-5.2M |
毛利率PBYIRPAY
| Q4 25 | 69.3% | 74.2% | ||
| Q3 25 | 77.7% | 74.4% | ||
| Q2 25 | 76.5% | 75.7% | ||
| Q1 25 | 77.1% | 75.9% | ||
| Q4 24 | 76.4% | 76.3% | ||
| Q3 24 | 63.9% | 77.8% | ||
| Q2 24 | 77.4% | 78.2% | ||
| Q1 24 | 75.5% | 76.2% |
营业利润率PBYIRPAY
| Q4 25 | 22.7% | -182.2% | ||
| Q3 25 | 17.6% | -3.9% | ||
| Q2 25 | 12.7% | -138.7% | ||
| Q1 25 | 8.7% | -4.7% | ||
| Q4 24 | 22.6% | -1.5% | ||
| Q3 24 | 27.4% | -0.9% | ||
| Q2 24 | -4.6% | -4.6% | ||
| Q1 24 | -5.3% | -3.1% |
净利率PBYIRPAY
| Q4 25 | — | -178.3% | ||
| Q3 25 | 16.2% | -8.3% | ||
| Q2 25 | 11.2% | -135.2% | ||
| Q1 25 | 6.5% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 25.2% | 4.1% | ||
| Q2 24 | -9.6% | -5.4% | ||
| Q1 24 | -11.0% | -6.5% |
每股收益（稀释后）PBYIRPAY
| Q4 25 | $0.26 | $-1.68 | ||
| Q3 25 | $0.17 | $-0.08 | ||
| Q2 25 | $0.12 | $-1.15 | ||
| Q1 25 | $0.06 | $-0.09 | ||
| Q4 24 | $0.40 | $-0.04 | ||
| Q3 24 | $0.41 | $0.03 | ||
| Q2 24 | $-0.09 | $-0.04 | ||
| Q1 24 | $-0.10 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $115.7M |
| 总债务越低越好 | $22.7M | $280.1M |
| 股东权益账面价值 | $130.3M | $484.4M |
| 总资产 | $216.3M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资PBYIRPAY
| Q4 25 | $97.5M | $115.7M | ||
| Q3 25 | $94.4M | $95.7M | ||
| Q2 25 | $96.0M | $162.6M | ||
| Q1 25 | $93.2M | $165.5M | ||
| Q4 24 | $101.0M | $189.5M | ||
| Q3 24 | $96.7M | $168.7M | ||
| Q2 24 | $96.8M | $147.1M | ||
| Q1 24 | $107.2M | $128.3M |
总债务PBYIRPAY
| Q4 25 | $22.7M | $280.1M | ||
| Q3 25 | $34.0M | $279.5M | ||
| Q2 25 | $45.3M | $279.0M | ||
| Q1 25 | $56.7M | $497.6M | ||
| Q4 24 | $68.0M | $496.8M | ||
| Q3 24 | $79.3M | $496.2M | ||
| Q2 24 | $90.7M | $435.6M | ||
| Q1 24 | $102.0M | $434.9M |
股东权益PBYIRPAY
| Q4 25 | $130.3M | $484.4M | ||
| Q3 25 | $115.3M | $616.9M | ||
| Q2 25 | $104.7M | $633.7M | ||
| Q1 25 | $97.1M | $755.7M | ||
| Q4 24 | $92.1M | $761.3M | ||
| Q3 24 | $71.1M | $754.7M | ||
| Q2 24 | $48.5M | $815.4M | ||
| Q1 24 | $51.0M | $813.8M |
总资产PBYIRPAY
| Q4 25 | $216.3M | $1.2B | ||
| Q3 25 | $202.9M | $1.3B | ||
| Q2 25 | $194.9M | $1.4B | ||
| Q1 25 | $196.2M | $1.5B | ||
| Q4 24 | $213.3M | $1.6B | ||
| Q3 24 | $220.7M | $1.6B | ||
| Q2 24 | $205.0M | $1.5B | ||
| Q1 24 | $214.1M | $1.5B |
负债/权益比PBYIRPAY
| Q4 25 | 0.17× | 0.58× | ||
| Q3 25 | 0.30× | 0.45× | ||
| Q2 25 | 0.43× | 0.44× | ||
| Q1 25 | 0.58× | 0.66× | ||
| Q4 24 | 0.74× | 0.65× | ||
| Q3 24 | 1.12× | 0.66× | ||
| Q2 24 | 1.87× | 0.53× | ||
| Q1 24 | 2.00× | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $23.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 29.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $90.7M |
8季度趋势，按日历期对齐
经营现金流PBYIRPAY
| Q4 25 | $14.4M | $23.3M | ||
| Q3 25 | $9.7M | $32.2M | ||
| Q2 25 | $14.1M | $33.1M | ||
| Q1 25 | $3.6M | $2.5M | ||
| Q4 24 | $15.6M | $34.3M | ||
| Q3 24 | $11.0M | $60.1M | ||
| Q2 24 | $1.0M | $31.0M | ||
| Q1 24 | $11.2M | $24.8M |
自由现金流PBYIRPAY
| Q4 25 | $14.4M | $23.2M | ||
| Q3 25 | $9.7M | $32.1M | ||
| Q2 25 | $14.1M | $33.0M | ||
| Q1 25 | $3.6M | $2.4M | ||
| Q4 24 | $15.6M | $34.0M | ||
| Q3 24 | $11.0M | $59.8M | ||
| Q2 24 | $1.0M | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率PBYIRPAY
| Q4 25 | 19.1% | 29.6% | ||
| Q3 25 | 17.7% | 41.3% | ||
| Q2 25 | 26.8% | 43.6% | ||
| Q1 25 | 7.7% | 3.0% | ||
| Q4 24 | 26.4% | 43.5% | ||
| Q3 24 | 13.7% | 75.6% | ||
| Q2 24 | 2.1% | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度PBYIRPAY
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.6% | ||
| Q1 24 | 0.0% | 0.1% |
现金转化率PBYIRPAY
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
